Debiopharm International Sa

This study is testing an experimental drug called Debio 0123 in 66 adults with advanced solid tumors that have grown after standard treatments or have no standard options. The first part finds the safest dose, and the second part checks safety and whether the drug can shrink tumo…

This study tests a new long-acting drug called Debio 4228 for men with advanced prostate cancer. The goal is to see how well it lowers testosterone, which can help control the cancer. About 66 men will receive different doses of the drug as a shot. This is not a cure, but a way t…

This study tests a new long-acting injection (Debio 4326) given once a year to children with central precocious puberty, a condition where puberty starts too early. The goal is to suppress hormones and pause puberty until a more typical age. About 56 children aged 2 to 8 years ar…